Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07406087 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Navigation Intervention for Adolescent and Young Adult Cancer Survivors

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment openedv4 Show 4 more changesShow less
    • Study sites: 0 to 1
    • Primary completion date: May 30, 2027 to Jun 2027
    • Start date changed from estimate of Nov 1, 2026 to Mar 15, 2026
    • Eligibility criteria expanded, about 5 words
  2. Minor Interventions: Adapted patient navigation program targeting adolescent and young adult cancer survivors (Other) to Adapted patient navigation program targeting adolescent and young adult cancer survivors (Behavioral)
    • Study description shortened, about 39 words
    v3
  3. Notable Primary endpoints: 7 to 1
    • Secondary endpoints expanded, about 10 words
    • Study description shortened, about 9 words
    • Eligibility criteria expanded, about 5 words
    v2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
5,418 trials monitored
See 296 trials at risk
3,394 trials monitored
See 159 trials at risk
and 6 more diseases
The investigators propose to: 1) Adapt an evidence-based cancer-focused patient navigation (PN) program for the Adolescent and Young Adult (AYA) cancer survivor population; and 2) Plan and conduct an effectiveness-implementation trial of this program within Kaiser Permanente Southern California (KPSC). PLEASE NOTE: This study is awarded in two phases. The UG3 phase has been awarded for the first two years; upon successful completion of this phase by meeting pre-defined milestones, the National Cancer Institute (NCI) will provide funding for the second phase of the study (Years 3-6), which will allow our team to conduct a trial to determine the effectiveness of the implementation of the adapted PN program for the AYA cancer survivor population. This application is focused on the initial UG3 phase and will update the protocol for the UH3 trial upon successful completion of the UG3 milestones and receipt of the UH3 award. The primary objectives in the UG3 phase of the study are to adapt and tailor an existing PN program to meet the needs of AYA cancer survivors and the local clinical context via (a) interviews with key stakeholders (patients, clinicians, administrators) and (b) guidance from our AYA Primary Care Survivorship Council. The investigators will conduct a pilot study of the adapted PN program and refine the program to enhance acceptability to patients and clinicians, enhance feasibility and effectiveness, and develop and pilot evaluation tools and methods prior to the start of the UH3 phase of the trial, which will be a larger trial. Objectives will be updated for the UH3 phase once awarded.
Trial Details
NCT Number NCT07406087
Lead Sponsor Kaiser Permanente
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)
Breast Cancer, Ovarian Cancer, Cervical Cancer, Testicular Cancer, Colon Rectal Cancer, Melanoma (Skin Cancer), Endometrial Cancer, Sarcoma +1 more
Related terms Breast Neoplasms, Colonic Neoplasms, Endometrial Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Testicular Neoplasms, Thyroid Neoplasms, Uterine Cervical Neoplasms
Enrollment 25 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov